RAVI I THADHANI

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Activated vitamin D sterols in kidney disease
    Ravi Thadhani
    Renal Unit and Center for D-Receptor Activation Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Lancet 371:542-4. 2008
  2. ncbi Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients
    Aminu K Bello
    Department of Medicine, University of Alberta, Edmonton, Canada
    BMC Nephrol 12:10. 2011
  3. ncbi Targeted ablation of the vitamin D 1alpha-hydroxylase gene: getting to the heart of the matter
    Ravi Thadhani
    Renal Unit and the Center for D Receptor Activation Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 74:141-3. 2008
  4. ncbi Vitamin D and hypertension: an update and review
    Hector Tamez
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Curr Opin Nephrol Hypertens 21:492-9. 2012
  5. ncbi Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients
    Ishir Bhan
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 82:84-9. 2012
  6. ncbi Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia
    Sarosh Rana
    Division of Maternal Fetal Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    PLoS ONE 7:e48259. 2012
  7. ncbi Genetic variation in APOL1 associates with younger age at hemodialysis initiation
    Zahra Kanji
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    J Am Soc Nephrol 22:2091-7. 2011
  8. ncbi Hypertension during pregnancy: a disorder begging for pathophysiological support
    RAVI I THADHANI
    Hypertension 46:1250-1. 2005
  9. ncbi Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension
    Winfred W Williams
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, USA
    N Engl J Med 353:2590-600. 2005

Research Grants

  1. Biological Measures and Hemodialysis Mortality
    Ravi Thadhani; Fiscal Year: 2006
  2. Gestational Diabetes and Preeclampsia Cytokine Profiles
    Ravi Thadhani; Fiscal Year: 2007
  3. Ergocalciferol in ESRD Efficacy Safety and Biology
    Ravi Thadhani; Fiscal Year: 2009
  4. Antibody Microarray Predicting Pima Diabetic Nephropathy
    Ravi Thadhani; Fiscal Year: 2005
  5. ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES
    Ravi Thadhani; Fiscal Year: 2005
  6. Ergocalciferol in ESRD Efficacy Safety and Biology
    Ravi Thadhani; Fiscal Year: 2010

Collaborators

  • Hector Tamez
  • Ishir Bhan
  • RICHARD JOSEPH JOHNSON
  • S Karumanchi
  • Sarosh Rana
  • Zahra Kanji
  • Marcello Tonelli
  • Aminu K Bello
  • Winfred W Williams
  • Steven J Ralston
  • Ana Sofia Cerdeira
  • Saira Salahuddin
  • Kee Hak Lim
  • Julia Wenger
  • Dorothy A Sullivan
  • George Cembrowski
  • Christopher Chan
  • Brenda Hemmelgarn
  • Elizabeth Ankers
  • Neil R Powe
  • Giulio Genovese
  • Andrea J Bernhardy
  • Sophanny Tiv
  • Mohammad Karkhaneh
  • Scott Klarenbach
  • John Gill
  • Natasha Wiebe
  • Gina Collerone
  • Salvatore Dibartolo
  • Daniel Holmes
  • Martin R Pollak
  • Rafael Sibrian
  • Dawn Opgenorth
  • David Friedman
  • Julia B Wenger
  • Chunmei Huang
  • Deborah Zimmerman
  • Camille E Powe
  • Aliyah Rahemtullah
  • Jeffrey L Ecker

Detail Information

Publications9

  1. ncbi Activated vitamin D sterols in kidney disease
    Ravi Thadhani
    Renal Unit and Center for D-Receptor Activation Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Lancet 371:542-4. 2008
  2. ncbi Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients
    Aminu K Bello
    Department of Medicine, University of Alberta, Edmonton, Canada
    BMC Nephrol 12:10. 2011
    ..This study focuses on delineating potentially reversible determinants of adverse outcomes that occur in patients receiving dialysis for end-stage renal disease (ESRD)...
  3. ncbi Targeted ablation of the vitamin D 1alpha-hydroxylase gene: getting to the heart of the matter
    Ravi Thadhani
    Renal Unit and the Center for D Receptor Activation Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 74:141-3. 2008
    ..In a study by Zhou et al., ablation of the 1alpha-hydroxylase gene led to hypertension, cardiac hypertrophy, and systolic dysfunction, and this cardiac phenotype was rescued with exogenous 1,25-dihydroxyvitamin D administration...
  4. ncbi Vitamin D and hypertension: an update and review
    Hector Tamez
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Curr Opin Nephrol Hypertens 21:492-9. 2012
    ..Vitamin D deficiency and hypertension are highly prevalent. This review will discuss the association between vitamin D deficiency and blood pressure...
  5. ncbi Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients
    Ishir Bhan
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Kidney Int 82:84-9. 2012
    ..Hence, bioavailable vitamin D levels are better correlated with measures of mineral metabolism than total levels in patients on hemodialysis...
  6. ncbi Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia
    Sarosh Rana
    Division of Maternal Fetal Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    PLoS ONE 7:e48259. 2012
    ....
  7. ncbi Genetic variation in APOL1 associates with younger age at hemodialysis initiation
    Zahra Kanji
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    J Am Soc Nephrol 22:2091-7. 2011
    ..In conclusion, genetic variations in APOL1 identify African Americans that initiate chronic hemodialysis at a younger age. Early interventions to prevent progression of kidney disease may benefit this high-risk population...
  8. ncbi Hypertension during pregnancy: a disorder begging for pathophysiological support
    RAVI I THADHANI
    Hypertension 46:1250-1. 2005
  9. ncbi Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension
    Winfred W Williams
    Division of Nephrology, Department of Medicine, Massachusetts General Hospital, USA
    N Engl J Med 353:2590-600. 2005

Research Grants14

  1. Biological Measures and Hemodialysis Mortality
    Ravi Thadhani; Fiscal Year: 2006
    ..We have in place detailed plans for the protection of patient privacy, inclusion of all patients, and data/sample sharing with the larger research community. ..
  2. Gestational Diabetes and Preeclampsia Cytokine Profiles
    Ravi Thadhani; Fiscal Year: 2007
    ..abstract_text> ..
  3. Ergocalciferol in ESRD Efficacy Safety and Biology
    Ravi Thadhani; Fiscal Year: 2009
    ..Our study is designed to determine safe and effective ways to raise vitamin D levels while monitoring effects on the immune system. ..
  4. Antibody Microarray Predicting Pima Diabetic Nephropathy
    Ravi Thadhani; Fiscal Year: 2005
    ..This R21 proposal may provide insight into the pathogenesis of DN, provide useful biomarkers to predict DN, and suggest early targets for intervention for this devastating disorder. ..
  5. ANDROGENS, LIPIDS, INSULIN AND HYPERTENSIVE PREGNANCIES
    Ravi Thadhani; Fiscal Year: 2005
    ..abstract_text> ..
  6. Ergocalciferol in ESRD Efficacy Safety and Biology
    Ravi Thadhani; Fiscal Year: 2010
    ..Our study is designed to determine safe and effective ways to raise vitamin D levels while monitoring effects on the immune system. ..